FDA approves Inlexzo for bladder cancer
The U.S. Food and Drug Administration has approved Inlexzo (gemcitabine intravesical system) for the treatment of patients with certain types of bladder cancer.
Sep 11, 2025
0
2
MeSH tree: C12.950.829
The U.S. Food and Drug Administration has approved Inlexzo (gemcitabine intravesical system) for the treatment of patients with certain types of bladder cancer.
Sep 11, 2025
0
2
Bladder cancer is a painful and often recurring disease, not just for humans, but for our canine companions as well. Urothelial carcinoma, the most common type of bladder cancer, affects both species in remarkably similar ...
For women with idiopathic overactive bladder (iOAB), both magnetic stimulation (MStim) and transcutaneous tibial nerve stimulation (TTNS) plus bladder training (BT) are more effective than BT alone, according to a study published ...
Aug 12, 2025
0
0
Adherence to a combination of healthy lifestyle factors is associated with a lower risk for overactive bladder (OAB), according to a study published online June 30 in Frontiers in Nutrition.
Jul 24, 2025
0
0
Childhood gastrointestinal (GI) disorders may be predictive for interstitial cystitis (IC), according to a study published online June 25 in Neurourology & Urodynamics.
Jul 22, 2025
0
0
For adults with neurogenic lower urinary tract dysfunction (NLUTD) or interstitial cystitis/bladder pain syndrome (IC/BPS), robot-assisted laparoscopic supratrigonal cystectomy with augmentation cystoplasty (RA-SC-AC) is ...
Jul 21, 2025
0
0
Chemotherapy used to target and kill bladder cancer cells may trigger an inflammatory response that ultimately may make the cancer more resistant to treatment, according to new research from scientists at Houston Methodist.
Jul 16, 2025
0
3
"Are we stopping again already?" It's a familiar complaint on family road trips and one that's often aimed at women. From sitcoms to stand-up routines, the idea that women have smaller bladders has become a cultural punchline. ...
Jul 7, 2025
0
0
Dietary patterns influence the development of overactive bladder (OAB), according to a study published online May 12 in Frontiers of Nutrition.
Jun 20, 2025
0
0
More than three decades ago, the U.S. Food and Drug Administration (FDA) approved Bacillus Calmette-Guérin (BCG) as the first immunotherapy against cancer. And it is still used today to treat early-stage bladder cancer.
May 29, 2025
0
29